Limits on physician access for reps continue to tighten
Latest SK&A survey finds more requirements for appointments, and more ‘no-see’ offices
The latest compilation of the regularly updated Office-Based Physician database of Irvine, CA-based SK&A indicates that 38.5% of U.S. physicians now require appointments to see them, up from 31.4% in the first half of 2008. The percentage of physicians who have banned sales-rep access altogether now stands at 23.6%, up 1.3% from the previous period. At hospital-owned medical practices, 31.2% have a “no-see” policy, and 44.6% require appointments. Access to physicians varies by region, with physicians practicing in the Southern U.S. being the most accessible and the Western U.S. being the least.
SK&A performs a telephone-based survey of practices and healthcare practitioners continuously, and compiles the data semiannually, as part of its database services for life sciences marketers, and custom reports.
Newsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.
Racial, Social, and Economic Factors Drive Resilience During COVID-19 Pandemic, Study Finds
July 18th 2025The study reveals that resilience varies significantly by race, education, income, and insurance status, highlighting the role of social determinants and systemic inequities in shaping health outcomes.
Thermo Fisher, Sanofi Expand Partnership to Boost Sterile Drug Production
July 16th 2025Per the deal, Thermo Fisher will acquire Sanofi’s sterile drug product manufacturing facility in Ridgefield, NJ, to support production of Sanofi therapies and expand capacity for US-based pharma and biotech manufacturing.
